Skip to main content
. Author manuscript; available in PMC: 2011 Mar 17.
Published in final edited form as: J Nucl Med. 2009 Oct 16;50(11):1794–1800. doi: 10.2967/jnumed.109.063743

TABLE 1.

Group Differences Detected with BPF-WM and BPF

Region BPF-WM (mL/mL) BPF (mL/mL)*
Controls Patients P Effect size P Effect size
I. sup. temporal 90 ± 26 77 ± 32 0.214 −0.53 0.280 −0.50
C. sup. temporal 86 ± 24 74 ± 27 0.199 −0.52 0.264 −0.49
I. mid. temporal 97 ± 28 80 ± 29 0.113 −0.60 0.154 −0.57
C. mid. temporal 93 ± 24 78 ± 25 0.096 −0.65 0.135 −0.63
I. inf. temporal 103 ± 29 80 ± 28 0.034 −0.78 0.052 −0.76
C. inf. temporal 100 ± 26 91 ± 32 0.423 −0.32 0.528 −0.29
I. fusiform 128 ± 35 82 ± 24 <0.001 −1.35 <0.001 −1.34
C. fusiform 122 ± 32 97 ± 32 0.041 −0.78 0.058 −0.76
I. parahippocampus 146 ± 38 84 ± 26 <0.001 −1.62 <0.001 −1.62
C. parahippocampus 146 ± 42 103 ± 29 0.002 −1.02 0.003 −1.02
I. hippocampus 129 ± 29 66 ± 31 <0.001 −2.20 <0.001 −2.22
C. hippocampus 126 ± 34 99 ± 30 0.025 −0.79 0.035 −0.78
I. amygdala 75 ± 17 51 ± 20 0.002 −1.39 0.005 −1.37
C. amygdala 77 ± 16 62 ± 22 0.045 −0.94 0.078 −0.89
I. insula 97 ± 28 64 ± 21 0.001 −1.18 0.001 −1.17
C. insula 97 ± 27 67 ± 20 0.001 −1.11 0.002 −1.10
I. frontal 70 ± 18 68 ± 23 0.643 −0.16 0.820 −0.11
C. frontal 67 ± 17 64 ± 23 0.648 −0.16 0.828 −0.11
I. parietal 65 ± 18 65 ± 22 0.914 0.01 0.890 0.06
C. parietal 64 ± 18 68 ± 24 0.761 0.20 0.593 0.26
I. occipital 41 ± 11 45 ± 13 0.524 0.39 0.298 0.51
R. occipital 39 ± 8 47 ± 16 0.235 1.02 0.130 1.10
*

Values obtained using VND as estimate of nondisplaceable binding (10).

I. = ipsilateral to focus; sup. = superior; C. = contralateral to focus; mid. = middle; inf. = inferior.